- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1758-9193
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Discordant amyloid-β PET and CSF biomarkers and its clinical consequences ; volume:11 ; number:1 ; day:12 ; month:9 ; year:2019 ; pages:1-13 ; date:12.2019
Alzheimer's research & therapy ; 11, Heft 1 (12.9.2019), 1-13, 12.2019
- Urheber
-
Wilde, Arno de
Reimand, Juhan
Teunissen, Charlotte E.
Zwan, Marissa
Windhorst, Albert D.
Boellaard, Ronald
Flier, Wiesje M. van der
Scheltens, Philip
Berckel, Bart N. M. van
Bouwman, Femke
Ossenkoppele, Rik
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13195-019-0532-x
- URN
-
urn:nbn:de:101:1-2020012704115795335661
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 14.08.2025, 10:47 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Wilde, Arno de
- Reimand, Juhan
- Teunissen, Charlotte E.
- Zwan, Marissa
- Windhorst, Albert D.
- Boellaard, Ronald
- Flier, Wiesje M. van der
- Scheltens, Philip
- Berckel, Bart N. M. van
- Bouwman, Femke
- Ossenkoppele, Rik
- SpringerLink (Online service)
Ähnliche Objekte (12)
PET and CSF amyloid-β status are differently predicted by patient features: information from discordant cases
Diagnostic Impact of CSF Biomarkers in a Local Hospital Memory Clinic Revisited
A decade of Alzheimer’s Research & Therapy: reflections on the past, present, and future
Heterogeneity of Alzheimer’s disease: consequence for drug trials?
Amyloid-β peptides in cerebrospinal fluid of patients with dementia with Lewy bodies
Regional [18F]flortaucipir PET is more closely associated with disease severity than CSF p-tau in Alzheimer’s disease
The “rights” of precision drug development for Alzheimer’s disease
Prevention of depression and sleep disturbances in elderly with memory-problems by activation of the biological clock with light - a randomized clinical trial
Testing Episodic Memory in Elderly Subjects: Not as Simple as It Looks
Associations between quantitative [18F]flortaucipir tau PET and atrophy across the Alzheimer’s disease spectrum
Altered brain metabolism in frontotemporal dementia and psychiatric disorders: involvement of the anterior cingulate cortex
Longitudinal change in ATN biomarkers in cognitively normal individuals
PET and CSF amyloid-β status are differently predicted by patient features: information from discordant cases
Diagnostic Impact of CSF Biomarkers in a Local Hospital Memory Clinic Revisited
A decade of Alzheimer’s Research & Therapy: reflections on the past, present, and future
Heterogeneity of Alzheimer’s disease: consequence for drug trials?
Amyloid-β peptides in cerebrospinal fluid of patients with dementia with Lewy bodies
Regional [18F]flortaucipir PET is more closely associated with disease severity than CSF p-tau in Alzheimer’s disease
The “rights” of precision drug development for Alzheimer’s disease
Prevention of depression and sleep disturbances in elderly with memory-problems by activation of the biological clock with light - a randomized clinical trial
Testing Episodic Memory in Elderly Subjects: Not as Simple as It Looks
Associations between quantitative [18F]flortaucipir tau PET and atrophy across the Alzheimer’s disease spectrum
Altered brain metabolism in frontotemporal dementia and psychiatric disorders: involvement of the anterior cingulate cortex
Longitudinal change in ATN biomarkers in cognitively normal individuals
PET and CSF amyloid-β status are differently predicted by patient features: information from discordant cases
Diagnostic Impact of CSF Biomarkers in a Local Hospital Memory Clinic Revisited
A decade of Alzheimer’s Research & Therapy: reflections on the past, present, and future
Heterogeneity of Alzheimer’s disease: consequence for drug trials?
Amyloid-β peptides in cerebrospinal fluid of patients with dementia with Lewy bodies
Regional [18F]flortaucipir PET is more closely associated with disease severity than CSF p-tau in Alzheimer’s disease
The “rights” of precision drug development for Alzheimer’s disease
Prevention of depression and sleep disturbances in elderly with memory-problems by activation of the biological clock with light - a randomized clinical trial
Testing Episodic Memory in Elderly Subjects: Not as Simple as It Looks
Associations between quantitative [18F]flortaucipir tau PET and atrophy across the Alzheimer’s disease spectrum
Altered brain metabolism in frontotemporal dementia and psychiatric disorders: involvement of the anterior cingulate cortex